CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 85 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2018. The put-call ratio across all filers is 3.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $287,000 | – | 3,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |